Skip to main content
Back to main menu

About Us

How we work

See what triggers an intervention and how supply and logistics allow our teams to respond quickly.

Learn more
How we're run

Discover our governance and what it means to be an association. Find a quick visual guide to our offices around the world.

Learn more
Reports and financials

Read through our annual financial and activity reports, and find out about where our funds come from and how they are spent.

Learn more
Accountability

Read the policies, reports, and plans on how we address issues like racism and reduce our carbon footprint, ensuring our actions align with the highest ethical standards.

Learn more

What we do

Médecins Sans Frontières brings medical humanitarian assistance to victims of conflict, natural disasters, epidemics or healthcare exclusion.

View all topics Activities by country
Featured Cholera Gaza Israel war Mediterranean migration

Where we work

In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.

View all countries
Featured Haiti Palestine Democratic Republic of Congo (DRC)

MSF Websites

A Global Network
Our offices around the world
Our offices around the world
Other Sites
View Resource Centre
MSF Access

MSF Access pushes for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.

GO TO SITE
CRASH

Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.

GO TO SITE
UREPH

Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.

GO TO SITE
ARHP

Based in Barcelona, ARHP documents and reflects on the operational challenges and dilemmas faced by the MSF field teams.

GO TO SITE
MSF Analysis

Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.

GO TO SITE
MSF Supply

This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
MSF Logistique

This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
Amsterdam Procurement Unit

This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.

GO TO SITE
Brazilian Medical Unit

BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.

GO TO SITE
MSF Medical Guidelines

Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.

GO TO SITE
Epicentre

Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.

GO TO SITE
Evaluation Units

Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.

GO TO SITE
LGBTQI+ Inclusion in Health Settings

MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.

GO TO SITE
LUXOR

The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.

GO TO SITE
MSF Academy for Healthcare

To upskill and provide training to locally-hired MSF staff in several countries, MSF has created the MSF Academy for Healthcare.

GO TO SITE
Humanitarian Law

This Guide explains the terms, concepts, and rules of humanitarian law in accessible and reader-friendly alphabetical entries.

GO TO SITE
MSF Paediatric Days

The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.

GO TO SITE
MSF Foundation

The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.

GO TO SITE
DNDi

A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.

GO TO SITE
MSF Science Portal

Our digital portal dedicated to sharing the latest medical evidence from our humanitarian activities around the globe.

GO TO SITE
Noma

Noma is a preventable and treatable neglected disease, but 90 per cent of people will die within the first two weeks of infection if they do not receive treatment.

GO TO SITE
TIC

The TIC is aiming to change how MSF works to better meet the evolving needs of our patients.

GO TO SITE
Telemedicine

MSF's telemedicine hub aims to overcome geographic barriers for equitable, accessible, and quality patient care.

GO TO SITE
Sweden Innovation Unit

Launched in 2012, the MSF Sweden Innovation Unit deploys a human-centered approach for promoting a culture of innovation within MSF.

GO TO SITE
Geo MSF

The GeoMSF platform is a dynamic one-stop-shop website for all of MSF's GIS related services and products. Access maps and applications through the catalogue, request geographical support, or produce a map on GeoMSF.

GeoMSF
Ebola disease in DRC: find out how we're responding
Learn more
8003 Results
 
msf-placeholder
Tuberculosis

New TB test to detect more people who need DR-TB treatment

WORLD TB DAY Press Release: A promising new diagnostic test will finally help detect more people with drug-resistant tuberculosis (DR-TB), increasing the urgency to solve major problems around the pricing and supply of DR-TB medicines, according to a new report by MSF. Press Release - 24 Mar 2011
 
msf-placeholder
War and conflict

Support to health facilities in the Middle East and North Africa

Ever since civil unrest and violence erupted in countries across North Africa and the Middle East, teams from Medecins Sans Frontieres (MSF) have been supplying and assisting hospitals and health structures where medical staff are facing increased numbers of injured people. Teams are also assisting people who are fleeing to neighbouring countries. Project Update - 23 Mar 2011
 
msf-placeholder
Libya

Normal health needs clearly go on despite the war in Libya

"In the few weeks that we spent in Benghazi, we managed to provide more than 30 tons of medical supplies to different hospitals including surgical kits and external fixators that are desperately needed for people with gunshot wounds." - Simon Burroughs: MSF emergency coordinator for Libya Voices from the Field - 23 Mar 2011
 
National Reference Laboratory, Abovyan. Sputum culture is currently used to detect TB, together with chest X-rays, sputum smear microscopy and Mantoux test. However, the growth of TB bacteria in culture is the only method allowing determining complete drug-susceptibility.<br> *** Local Caption *** Treatment options for patients with drug-resistant TB remain far short of what is needed. Treatments are long (up to 2 years), toxic (serious side-effects) and expensive. Furthermore, the cure rate is only 50%. Bedaquiline, one of two new TB drugs to be developed in 50 years, is as yet only available for compassionate use, i.e., patients for whom most antibiotics are not effective. MSF has been administering a new treatment including bedaquiline to around thirty patients in Armenia since April 2013. Although we can not draw any definitive conclusions (at this point), several patients have shown significant signs of improvement and we have not observed any side effects associated with bedaquiline until now. But, while compassionate use of this new drug gives cause for optimism to patients who have lost hope, it is not the solution for treating the hundreds of thousands of patients worldwide suffering from DR-TB. New, shorter, less toxic and cheaper treatments including bedaquiline and delamanid, the other new TB drug, need to be developed.
Tuberculosis

DR-TB drugs under the microscope

Treating DR-TB is complicated from a programmatic perspective: treatment is individualised, tailored according to which drugs a patient is resistant to. It is long and taxing, requiring people to take a course of antibiotics for up to two years and endure often intolerable side effects. Report - 23 Mar 2011
 
msf-placeholder
Japan

Interview with Eric Ouannes, General Director of MSF Japan

Interview with Eric Ouannes, General Director of MSF Japan, who has been working at the earthquauke zone. Project Update - 20 Mar 2011
 
msf-placeholder
Japan

MSF continues to respond to chronic diseases for the elderly in Japan's evacuation centres

The situation in areas seen by MSF’s team in northern Miyagi prefecture is evolving quickly, as the massive national relief effort clears access to areas and large quantities of relief supplies continue to come in. Photo Story - 20 Mar 2011
 
msf-placeholder
Côte d'Ivoire

MSF responding to latest violence in Abidjan, Ivory Coast

Increasingly intense confrontations have had serious repercussions for the population at large, much of which has been trapped in the conflict. Over the two weeks prior to March 16, the teams treated 129 patients. However, seeking treatment is not a simple matter for people who require care but are afraid to leave their homes. Travel within the city is risky because of fighting and because groups of young men have erected blockades in the streets. The instability makes it difficult to access populations, particularly in areas close to the front lines. Project Update - 19 Mar 2011
 
msf-placeholder
Japan

MSF teams spread to new areas throughout the earthquake zone

The majority of consultations were elderly patients with chronic diseases. Many of them were running out of medications for hypertension and diabetes. Overnight, the weather in the area was poor, with snow and sub-zero temperatures. A few hyperthermia cases were seen, as well as some respiratory tract infections, possibly due to the crowded conditions in some of the evacuation centres. Project Update - 17 Mar 2011
 
msf-placeholder
Côte d'Ivoire

Ivory Coast population trapped in conflict

Increasingly intense armed confrontations over recent weeks in Ivory Coast, together with political gridlock, have had serious consequences on the country’s population. Fighting has led to new displacements of people in the capital, Abidjan, and in the western region of the country. Insecurity and shortages of medicine resulting from international sanctions have made it very difficult for victims of violence - and all those in need - to obtain care. Project Update - 16 Mar 2011
 
msf-placeholder
Japan

MSF works in isolated Japanese community devastated by quake

From Tuesday, MSF staff plan to start a small clinic in another town near to Minamisanriku using drugs donated on Monday. Once additional medical resources from the massive Japanese relief effort arrive, MSF will try to find other pockets of communities who may need medical assistance. Project Update - 16 Mar 2011
Four mothers posing in a corridor of the Hospital in Bili. All four of them are staying in the hospital with their child, that's suffering from a severe case of malaria. Since the beginning of the project in 2016, the pediatric ward already treated more than 4.000 cases of complicated/severe form of malaria.
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more